Navigation Links
Einstein researcher helps lead consortium for $10 million 'X Prize' to sequence genomes of 100 centenarians
Date:10/26/2011

October 26, 2011 (BRONX, NY) Nir Barzilai, M.D., director of the Institute for Aging Research at Albert Einstein College of Medicine of Yeshiva University, will help lead a newly formed centenarian consortium for the Archon Genomics X PRIZE presented by Medco. The $10 million dollar incentivized prize competition, which was announced today, challenges teams of scientists and entrepreneurs to sequence the complete genomes of 100 healthy centenarians in 30 days. Intended to help usher in an era of personalized medicine and learn from the genetic advantages of the exceptionally long-lived, the competition tasks teams with delivering medical quality genome sequencing results for $1,000 per centenarian.

As one of the leaders of the centenarian consortium, Dr. Barzilai will help identify and collect the 100 centenarian genomes to be sequenced. Known as the Medco 100 Over 100, the genomes will be donated by 100 vital and independent individuals who are aged 100 or older and have participated in a centenarian study, like Dr. Barzilai's Longevity Genes Project. One of Dr. Barzilai's participants, 105-year old Irving Kahn who founded a successful New York City-based value investment firm and still works daily participated in today's X PRIZE announcement event.

Dr. Barzilai, who has been studying the healthy elderly since 1998, implicated several "longevity genes" in humans. His research on more than 500 centenarians of Ashkenazi Jewish descent established, among other findings, that the gene variant that leads to high HDL, or "good cholesterol," is linked to healthy aging and extreme longevity.

"Understanding the genetic makeup that protects these healthy centenarians from Alzheimer's disease, diabetes, cancer and other diseases associated with aging is necessary if we all want to live disease-free into an advanced old age," said Dr. Barzilai, the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the NIH-funded Nathan Shock Center of Excellence in the Basic Biology of Aging at Einstein. "By sequencing the genomes of these healthy centenarians and making the results available to scientists this contest will be a powerful tool in helping us decode the genetic underpinnings of healthy aging and develop drugs that can mimic the protections these individuals have."

"The assistance of Dr. Barzilai and the other centenarian consortium members have been critical for creating this contest," said Grant Campany, senior director of the AGXP. "Without them we would not have the genomic material for this invaluable research that may bring us one step closer to realizing the promise of personalized medicine."

The 30-day Archon Genomics X PRIZE competition begins on Thursday, January 3, 2013; winners will be announced that spring.


'/>"/>

Contact: Kimberly Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. Einstein College of Medicine receives $5.7 million for developmental disabilities research
2. Einstein to utilize electronic medical records system to analyze HIV/AIDS in central Africa
3. Einstein scientists find crucial molecule involved in spread of breast cancer
4. Einstein secures $11 million to continue research on brain aging and Alzheimers disease
5. Einstein Montefiore lung specialist to receive award for work with 9/11 rescue workers
6. Feinstein scientists identify abnormal disease pathway in dystonia
7. Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research
8. Einstein-Montefiore researcher will test nanoparticles against pancreatic cancer
9. ALBERT EINSTEIN COLLEGE OF MEDICINE HELPS ADDRESS NEED FOR IMPROVED CANCER CARE IN RURAL AMERICA
10. Feinstein Institute to share $5M US Department of Defense grant
11. Einstein scientist awarded $4 million to develop genetic strategy to combat tuberculosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... ... Infusion Nurses Society (INS) states that vein visualization technology should be used to ... healthcare facilities around the world, the INS Standards mandate the use of vein ...
(Date:2/12/2016)... ... February 12, 2016 , ... According to an article published February ... a significant portion of hernia repairs throughout the United States. Commenting on this article, ... notes that this trend has not only been expected, but it seems to be ...
(Date:2/12/2016)... , ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future ... , As Winston Churchill said, “Those who don’t learn from history are doomed ... to expect when they come knocking this year. But that takes time. , Take ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... announced that nominations have closed for the ISE Southeast Awards 2016. Finalists and ... announced at the ISE® Southeast Executive Forum and Awards Gala on March 15, ...
(Date:2/12/2016)... ... ... AssureVest Insurance Group, a locally owned insurance firm with offices serving Washington NC ... to purchase computers and software for Mrs. Harrison’s 2nd and 3rd grade special needs ... area and has more than 60 2nd and 3rd graders with learning disabilities. A ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12, 2016 On Thursday, Feb. 11, 2016, ... St. David,s North Austin Medical Center successfully completed the ... Xi ® Surgical System with Trumpf Medical,s advanced ... Thiru Lakshman , M.D., colorectal surgeon at the Texas ... Integrated Table Motion technology, which seamlessly combines the da ...
(Date:2/12/2016)... , Feb. 12 2016  OMS Supply, a large ... medical practitioners, announced today the recent launching of their ... a variety of features that enhance the user experience ... supplies. --> --> ... fairly new company that started in early 2016, they ...
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
Breaking Medicine Technology: